✦ LIBER ✦

Immunotherapy in metastatic renal cell carcinoma

✍ Scribed by Karl Rohrmann; Michael Staehler; Nikolas Haseke; Alexander Bachmann; Christian G. Stief; Michael Siebels

Publisher: Springer-Verlag
Year: 2005
Tongue: English
Weight: 237 KB
Volume: 23
Category: Article
ISSN: 0724-4983
DOI: 10.1007/s00345-004-0470-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination of surgery and immunotherapy

Combination of surgery and immunotherapy in metastatic renal cell carcinoma

✍ Gerald H. Mickisch; Roland H. Mattes 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 187 KB

Sarcomatoid differentiation as a prognos

Sarcomatoid differentiation as a prognostic factor for immunotherapy in metastatic renal cell carcinoma

✍ Cheol Kwak; Yong Hyun Park; Chang Wook Jeong; Hyeon Jeong; Sang Eun Lee; Kyung C 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Leukocyte orchestration in blood and tum

Leukocyte orchestration in blood and tumour tissue following interleukin-2 based immunotherapy in metastatic renal cell carcinoma

✍ Frede Donskov; Karen Marie Bennedsgaard; Marianne Hokland; Niels Marcussen; Rune 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 382 KB

Phase II study of fotemustine as second-

Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinoma

✍ Christine Lassel; Yacine Merrouche; Sylvie Negrier; Paul Rebattu; Jocelyne Beril 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 265 KB

Successful adoptive immunotherapy of met

Successful adoptive immunotherapy of metastatic renal cell carcinoma with in vitro immunized autologous lymphocytes and cimetidine

✍ Michael E. Osband; Gennaro A. Carpinito; Steven I. Levine; Dylan H. Hamilton; Ro 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 497 KB

Granulocyte-macrophage–colony stimulatin

Granulocyte-macrophage–colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma : Results of two Phase II clinical trials

✍ Christopher W. Ryan; Nicholas J. Vogelzang; Mary C. Dumas; Timothy Kuzel; Walter 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

The aim of this study was to determine the response rates and toxicity of two regimens containing granulocyte-macrophage-colony stimulating factor (GM-CSF) in combination with interleukin-2 (IL-2) in the treatment of patients with metastatic renal cell carcinoma. ## METHODS. Therapy given in the f